Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
2 other identifiers
observational
94
1 country
1
Brief Summary
The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with pulmonary Langerhans cell histiocytosis (PLCH). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the Histiocytosis Association website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 200 patients with PLCH for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 9, 2017
CompletedFirst Posted
Study publicly available on registry
February 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedResults Posted
Study results publicly available
January 31, 2024
CompletedJanuary 31, 2024
January 1, 2024
2.5 years
February 9, 2017
September 18, 2023
January 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With PLCH Who Experienced Spontaneous Pneumothorax During or Within 24 Hours Following Air Travel
The investigators will measure the number of pneumothoraces that occur either during air travel, or within 24 hours of air travel among patients with pulmonary Langerhans cell histiocytosis. The incidence of air travel related pneumothorax will be calculated by dividing the number of pneumothoraces to the total number of flights undertaken by the entire cohort.
During air travel or within 24 hours following air travel
Secondary Outcomes (2)
Number of Patients With Pulmonary Langerhans Cell Histiocytosis Who Experienced a Spontaneous Pneumothorax
2 years and 6 months
Number of Patients With Pulmonary Langerhans Cell Histiocytosis Who Experienced Recurrent Pneumothorax
2 years and 6 months
Eligibility Criteria
Patients diagnosed with Pulmonary Langerhans Cell Histiocytosis
You may qualify if:
- Adult, age 18 or older
- English literate
- Signed, dated informed consent; either given electronically or via paper form
- Confirmed diagnosis of PLCH based either on characteristic radiologic findings, or histopathological confirmation
You may not qualify if:
- Inability, or refusal, to sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Cincinnatilead
- Rare Diseases Clinical Research Networkcollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
University of Cincinnati
Cincinnati, Ohio, 45267-0564, United States
Related Publications (1)
Singla A, Kopras EJ, Gupta N. Spontaneous pneumothorax and air travel in Pulmonary Langerhans cell histiocytosis: A patient survey. Respir Investig. 2019 Nov;57(6):582-589. doi: 10.1016/j.resinv.2019.07.004. Epub 2019 Sep 26.
PMID: 31563637DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Elizabeth Kopras
- Organization
- University of Cincinnati
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 9, 2017
First Posted
February 14, 2017
Study Start
June 1, 2016
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
January 31, 2024
Results First Posted
January 31, 2024
Record last verified: 2024-01